U.S. Professional Services Stock News

Box (BOX) has expanded its equity buyback plan, adding US$500 million in authorization to reach US$1.86b and extending the program through September 30, 2027. This move refocuses attention on capital returns. See our latest analysis for Box. At a share price of US$23.32, Box has a 90 day share price return of 23.31% and a one year total shareholder return of 24.43% decline, pointing to fading momentum even as the larger buyback program draws fresh attention from investors. If you are weighing...

If you are wondering whether XPeng's share price reflects its real worth, or if the market is mispricing the story, this article walks you through what the numbers are actually saying. XPeng's stock last closed at US$16.72, with returns of an 11.4% decline over 7 days, 4.8% decline over 30 days, 18.2% decline year to date and 19.3% decline over 1 year, set against a 52.0% gain over 3 years and 53.6% decline over 5 years. These mixed returns sit against a backdrop of ongoing headlines about...

We wouldn't blame Hewlett Packard Enterprise Company ( NYSE:HPE ) shareholders if they were a little worried about the...

Investors were underwhelmed by the solid earnings posted by Kanzhun Limited ( NASDAQ:BZ ) recently. We did some digging...

Rising geopolitical tensions linked to the Iran war are raising fresh concerns about semiconductor supply chains. Helium, a key material for chip manufacturing, is in focus as potential disruption risks resurface. KLA Corporation (NasdaqGS:KLAC), a major supplier of process control and metrology tools to chip fabs, sits close to these supply chain fault lines. KLA earns much of its business from equipment and services that depend on stable fab activity and access to advanced materials such...

If you are wondering whether Booz Allen Hamilton Holding is attractively priced right now or if the recent share level is hard to justify, this breakdown focuses squarely on what you are getting for the price you pay. The stock last closed at US$78.95, with returns of a 1.2% decline over 7 days, 0.2% over 30 days, and year-to-date and 1-year returns of a 7.0% decline and 22.6% decline. These figures may prompt questions about whether sentiment or valuation has shifted too far. Recent news...

MoonLake Immunotherapeutics: recent stock performance snapshot MoonLake Immunotherapeutics (MLTX) has seen mixed trading moves recently, with the stock down 2.3% over the past day and roughly 3.3% over the past month, while showing a gain of about 28% in the past 3 months. See our latest analysis for MoonLake Immunotherapeutics. The current share price of $16.93 sits alongside a 90 day share price return of 28.45% and a year to date share price return of 41.67%. In contrast, the 1 year total...

Over the last 7 days, the United States market has experienced a 3.5% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this fluctuating environment, identifying stocks that are potentially undervalued and have notable insider activity can be key to uncovering promising opportunities in the small-cap sector.

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health that can capitalize on long-term trends despite short-term fluctuations.

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year, with earnings projected to grow by 15% annually. In this context, finding stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on long-term growth prospects amidst fluctuating market conditions.

Over the last 7 days, the United States market has experienced a 3.5% drop, yet it has risen by 14% over the past year with earnings projected to grow by 15% annually in the coming years. In this environment, growth companies with high insider ownership can be particularly appealing as they may align management's interests with shareholders and potentially drive significant earnings growth.

Over the last 7 days, the U.S. market has dropped 3.5%, but it has risen by 14% over the past year, with earnings forecasted to grow annually by 15%. Investing in penny stocks — a term that may feel outdated yet remains relevant — can still provide access to growth opportunities, especially within smaller or newer companies. By focusing on those with robust financials and clear growth potential, investors can uncover valuable opportunities among these lesser-known stocks.

Over the last 7 days, the United States market has dropped 3.5%, yet it has seen a robust rise of 14% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering undiscovered gems worth exploring in March 2026.

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings anticipated to grow by 15% annually in the coming years. In this fluctuating environment, dividend stocks that offer substantial yields can provide a reliable income stream and potential stability for investors seeking consistent returns amidst market volatility.

The recent 10% drop in Candel Therapeutics, Inc.'s ( NASDAQ:CADL ) stock could come as a blow to insiders who purchased...

Insiders who purchased Vera Bradley, Inc. ( NASDAQ:VRA ) shares in the past 12 months are unlikely to be deeply...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Goosehead Insurance (NasdaqGS:GSHD) has appointed Martin Thornthwaite as General Counsel and Corporate Secretary. Thornthwaite succeeds John O’Connor, whose departure prompted the leadership change in the company’s top legal role. The move affects oversight of legal, governance, and regulatory matters at Goosehead Insurance. For investors watching Goosehead Insurance at a share price of $42.3, this change comes after a period of pressure on the stock. The company’s shares have seen a 22.0%...

Wondering if Mirum Pharmaceuticals at around US$87.90 is still offering value after a strong run, or if most of the opportunity is already reflected in the price. The stock has been flat over the past week, recorded a 4.8% decline over the last 30 days, yet is up 12.6% year to date and 99.6% over the past year, with a very large 3 year gain of 252.3% and a 5 year gain of 340.6%. Recent coverage has focused on Mirum Pharmaceuticals as a fast moving biotech name. This helps frame why the share...

The Morning Bull - US Market Morning Update Tuesday, Mar, 31 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 and Nasdaq-100 contracts up around 0.8%, as investors balance relief over interest rates with fresh worries about energy costs. The US 10 year Treasury yield sits near 4.32% after comments from the Federal Reserve suggested inflation expectations remain in check, which helps keep borrowing costs for mortgages, car loans and companies from climbing more...

Insiders who acquired US$5.09m worth of NovaBridge Biosciences' ( NASDAQ:NBP ) stock at an average price of US$3.89 in...

We'd be surprised if Critical Metals Corp. ( NASDAQ:CRML ) shareholders haven't noticed that the Independent Director...

If you are wondering whether Urban Outfitters at around US$60.93 is still attractively priced or already stretched, the starting point is to understand what the current share price actually reflects. The stock has seen a 1.3% decline over the last week and an 8.0% decline over the last 30 days, yet it still sits on a 16.3% one-year return and a 121.4% three-year return, which can change how investors think about both growth potential and risk. Recent coverage has focused on Urban Outfitters...

Investors may be asking whether Acuity at around US$272.42 is offering good value right now, or if the recent price places it on the more expensive side. The stock is around 27.0% lower year to date, with a 9.7% decline over the last 30 days, while the 1 year and 3 year returns of 3.7% and 49.7% remain positive. These moves sit against a backdrop where Acuity continues to attract investor attention as an established player in lighting and building management solutions. Any shifts in...